189
Views
10
CrossRef citations to date
0
Altmetric
Research Articles

Alogliptin attenuates cyclophosphamide-induced nephrotoxicity: a novel therapeutic approach through modulating MAP3K/JNK/SMAD3 signaling cascade

ORCID Icon, , , &
Pages 1254-1263 | Received 06 Mar 2020, Accepted 18 Aug 2020, Published online: 01 Sep 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ashif Iqubal, Abul Kalam Najmi, Shadab Md, Huda Mohammed Alkreathy, Javed Ali, Mansoor Ali Syed & Syed Ehtaishamul Haque. (2023) Oral delivery of nerolidol alleviates cyclophosphamide-induced renal inflammation, apoptosis, and fibrosis via modulation of NF-κB/cleaved caspase-3/TGF-β signaling molecules. Drug Delivery 30:1.
Read now

Articles from other publishers (9)

Nehal Mohsin, Mohammad Shabib Akhtar, Saad A Alkahtani, Ismail A Walbi, Yasir Alhazmi, Md. Niyaz Alam & Alok Bhardwaj. (2024) Nephroprotective Effect of Bergapten Against Cyclophosphamide-Mediated Renal Stress, Inflammation, and Fibrosis in Wistar Rats: Probable Role of NF-kB and TGF-β1 Signaling Molecules. ACS Omega 9:16, pages 18296-18303.
Crossref
Yarini Arrebola Sánchez, Fabiola Almeida García, Daniel Ojeda del Sol, Mario E. Valdés-Tresanco, Carlos David Ortiz, Belinda Sánchez Ramírez & Isel Pascual Alonso. (2023) Dipeptidyl peptidase IV: a multifunctional enzyme with implications in several pathologies including cancer. Physical Sciences Reviews 0:0.
Crossref
Tuba Ozcan Metin, Ahmet Turk, Alper Yalcın & Ilkay Adanır. (2023) Anti-inflammatory and anti-apoptotic potential of beta-glucan on chemotherapy-induced nephrotoxicity in rats. Journal of Surgery and Medicine 7:1, pages 35-39.
Crossref
Ruili Yin, Yongsong Xu, Xin Wang, Longyan Yang & Dong Zhao. (2022) Role of Dipeptidyl Peptidase 4 Inhibitors in Antidiabetic Treatment. Molecules 27:10, pages 3055.
Crossref
Amira Ebrahim Alsemeh & Doaa M. Abdullah. (2022) Protective effect of alogliptin against cyclophosphamide-induced lung toxicity in rats: Impact on PI3K/Akt/FoxO1 pathway and downstream inflammatory cascades. Cell and Tissue Research 388:2, pages 417-438.
Crossref
Petr Busek, Jonathan S. Duke-Cohan & Aleksi Sedo. (2022) Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease?. Cancers 14:9, pages 2072.
Crossref
Muluken Altaye Ayza, Kaleab Alemayehu Zewdie, Elias Fitsum Yigzaw, Solomon Gashaw Ayele, Bekalu Amare Tesfaye, Gebrehiwot Gebremedhin Tafere & Muzey Gebreyohannes Abrha. (2022) Potential Protective Effects of Antioxidants against Cyclophosphamide-Induced Nephrotoxicity. International Journal of Nephrology 2022, pages 1-12.
Crossref
Xueyan Yang, Jun Feng, Wei Liang, Zijing Zhu, Zhaowei Chen, Jijia Hu, Dingping Yang & Guohua Ding. (2021) Roles of SIRT6 in kidney disease: a novel therapeutic target. Cellular and Molecular Life Sciences 79:1.
Crossref
Adel M. Ahmad, Hamdoon A. Mohammed, Tarek M. Faris, Abeer S. Hassan, Hebatallah B. Mohamed, Mahmoud I. El Dosoky & Esam M. Aboubakr. (2021) Nano-Structured Lipid Carrier-Based Oral Glutathione Formulation Mediates Renoprotection against Cyclophosphamide-Induced Nephrotoxicity, and Improves Oral Bioavailability of Glutathione Confirmed through RP-HPLC Micellar Liquid Chromatography. Molecules 26:24, pages 7491.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.